VenturEast — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Diabetomicsdiabetomics.comOct 2014
ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders.
BiotechDigital HealthHealthtechMedical DevicesHillsboro, US
Dave Gunderson(Executive Officer, Director)Rick Miller(Director)Chris Dudley(Director)Robert Gregg(Director)Robert Gootee(Director)Srinivasa Rao Nagalla(Executive Officer, Director, Promoter)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.